Pause on Johnson & Johnson COVID vaccine in U.S lifted by FDA, use to resume.
Johnson & Johnson s COVID vaccine will be made available to the public again, ending an 11-day pause initiated after a rare blood clotting disorder was associated with the shot.
The Food and Drug Administration and Centers for Disease Control and Prevention determined the benefits of the J&J vaccine outweighed the risks of keeping it off the market. Out of nearly 8 million who received the vaccine, 15 people have developed the condition and three have died.
The two agencies held a joint news conference Friday evening to announce their decision to allow distribution of the J&J vaccine to resume. | Read more
Kaiser Health News
The U.S. government has invested billions of dollars in manufacturing, used a wartime act dozens of times to boost supplies and yet there’s still not enough covid vaccine on the way to meet demand - or even the government’s own goals for national immunization.
Please share this article - Go to very top of page, right hand side, for social media buttons.
President Joe Biden, in remarks at the National Institutes of Health this month, said the nation is “now on track to have enough supply for 300 million Americans by the end of July. But at the current rate of production, Pfizer and Moderna will miss their targets of providing at least 100 million doses each by the end of March, let alone 200 million more doses each has promised by July.
Not yet inoculated against misleading statements. (White House)
“When I came into office, the prior administration had contracted for not nearly enough vaccine to cover adults in America. We rectified that.”
During a March 2 news conference on the covid-19 pandemic, President Joe Biden claimed that former President Donald Trump’s administration did not ensure there would be enough vaccines for the American public.
“When I came into office, the prior administration had contracted for not nearly enough vaccine to cover adults in America,” said Biden. “We rectified that.”
Biden then announced he was using the Defense Production Act to facilitate a partnership between two competing drug companies: Merck had agreed to help manufacture the recently authorized Johnson & Johnson vaccine.
Biden s Criticism of Trump Team s Vaccine Contracts Is a Stretch medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.